Jian-wen Chen

发表

Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9+ renal tubular cells

Wu, Fei Li, Xueyuan Bai, 2022, Theranostics.

Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk.

B. Forbes, J. Frystyk, A. Flyvbjerg, 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Homozygous and heterozygous expression of a novel IGF-I mutation 6

Jeroen J. Bax, J. Romijn, S. Mohan, 2007 .

Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.

J. Frystyk, A. Flyvbjerg, A. Larnkjaer, 2006, European journal of endocrinology.

Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum

J. Frystyk, H. Grønbæk, A. Flyvbjerg, 2010, Clinical endocrinology.

Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.

J. Frystyk, J. Jørgensen, C. Hagen, 2005, The Journal of clinical endocrinology and metabolism.

Residual β-Cell Function More than Glycemic Control Determines Abnormalities of the Insulin-Like Growth Factor System in Type 1 Diabetes

J. Frystyk, A. Flyvbjerg, H. Arnqvist, 2004 .

A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.

H. Orskov, J. Frystyk, J. Christiansen, 2003, American journal of physiology. Endocrinology and metabolism.

Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.

H. Orskov, K. Højlund, H. Beck-Nielsen, 2005, The Journal of clinical endocrinology and metabolism.

Response to Comment on Home et al. Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237–1245

P. Home, Z. Latif, M. Hasan, 2014, Diabetes Care.

Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.

J. Frystyk, J. Christiansen, A. Flyvbjerg, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.

M. Overgaard, C. Oxvig, J. Frystyk, 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Normal Growth Spurt and Final Height despite Low Levels of All Forms of Circulating Insulin-Like Growth Factor-I in a Patient with Acid-Labile Subunit Deficiency

J. Frystyk, Jian-Wen Chen, J. Heinrich, 2007, Hormone Research in Paediatrics.

Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock.

W. Wu, Zitong Huang, Longyuan Jiang, 2005, World journal of gastroenterology.

The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease.

J. Frystyk, A. Flyvbjerg, G. Krassas, 2004, Hormones.

Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa.

J. Frystyk, A. Flyvbjerg, D. Glintborg, 2007, The Journal of clinical endocrinology and metabolism.

Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries

P. Home, S. Guler, P. Soewondo, 2013, Diabetes Therapy.

Limitations to subcutaneous insulin administration in type 1 diabetes

T. Lauritzen, J. Christiansen, Jian-Wen Chen, 2003, Diabetes, obesity & metabolism.

Brief, high intensity exercise alters serum ghrelin and growth hormone concentrations but not IGF-I, IGF-II or IGF-I bioactivity.

J. Frystyk, K. Stokes, Jian-wen Chen, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.

A. Caumo, J. Frystyk, J. Christiansen, 2006, European journal of endocrinology.

Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs

P. Home, Z. Latif, M. Hasan, 2014, Diabetes Care.

Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants.

D. Dunger, K. Ong, J. Frystyk, 2007, The Journal of pediatrics.

Raised Serum Sialic Acid Concentration in NIDDM Patients With and Without Diabetic Nephropathy

H. Parving, J. Jensen, H. Yokoyama, 1996, Diabetes Care.

Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms.

Erik Mosekilde, Maria Thomsen, E. Mosekilde, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study.

L. Chuang, G. Dieuzeide, F. Lavalle-González, 2014, Primary care diabetes.

Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes

J. Christiansen, Jian-Wen Chen, H. Thomsen, 2007, Journal of diabetes science and technology.

A. Shinde, S. Assaad-Khalil, R. Malek, 2015, Diabetes & metabolism.

Brief, high intensity exercise alters serum ghrelin and growth hormone concentrations but not IGF-I, IGF-II or IGF-I bioactivity.

J. Frystyk, K. Stokes, Jian-wen Chen, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.

J. Frystyk, A. Flyvbjerg, H. Arnqvist, 2004, The Journal of clinical endocrinology and metabolism.

Safety and Effectiveness of Bolus Insulin Aspart in People with Type 2 Diabetes: A1chieve Sub-Analysis

M. Khamseh, L. Zajdenverg, A. Liebl, 2013, Diabetes Therapy.

Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results

Z. Hussein, Jian-Wen Chen, P. Soewondo, 2013, Diabetes Therapy.

A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.

J. Christiansen, N. Ejskjaer, T. Parkner, 2009, Basic & clinical pharmacology & toxicology.